ArticleNeuropsychiatric disease and treatment2025
Potential Mitochondria-Related Key Genes in Post-Traumatic Stress Disorder Analyzed by Machine Learning Methods.
Article in Neuropsychiatric disease and treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Post-traumatic stress disorder (PTSD) is a debilitating psychiatric disorder triggered by exposure to traumatic events. Emerging evidence suggests that mitochondrial dysfunction may contribute to PTSD pathogenesis by disrupting cellular energy metabolism, increasing oxidative stress, and impairing neuroplasticity. This study investigates mitochondrial dysfunction-associated biomarkers, potentially opening new avenues for targeted therapeutic approaches. Methods: Gene expression matrices from datasets GSE199841 and GSE81761 were derived from peripheral blood samples, used to identify differentially expressed genes (DEGs) between PTSD patients and healthy controls. Functional annotation and enrichment analysis were carried out using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses. Next, least absolute shrinkage and selection operator (LASSO), support vector machine recursive feature elimination (SVM-RFE), and random forest were employed to screen and prioritize potential biomarkers, followed by validation through receiver operating characteristic (ROC) analysis and independent cohort from human verification. We also examined the expression of mitoDEGs in peripheral blood from PTSD-related mouse models by RT-qPCR. Given the close interplay between mitochondrial metabolism and immune function, we investigated the relationship between key MitoDEGs and immune infiltration proportions. Results: DEGs in PTSD were enriched in mitochondrial pathways, including mitochondrial ribosome function and nitric oxide synthase regulation. Machine learning identified Conclusion: Mitochondrial-related genes
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.